Annual Working Capital
$255.18 M
+$203.27 M+391.59%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual working capital is $255.18 million, with the most recent change of +$203.27 million (+391.59%) on December 31, 2023.
- During the last 3 years, VYGR annual working capital has risen by +$84.17 million (+49.22%).
- VYGR annual working capital is now at all-time high.
Performance
VYGR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$329.23 M
-$12.21 M-3.58%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly working capital is $329.23 million, with the most recent change of -$12.21 million (-3.58%) on September 30, 2024.
- Over the past year, VYGR quarterly working capital has increased by +$74.06 million (+29.02%).
- VYGR quarterly working capital is now -3.58% below its all-time high of $341.44 million, reached on June 30, 2024.
Performance
VYGR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
VYGR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +391.6% | +29.0% |
| 3 y3 years | +49.2% | +534.3% |
| 5 y5 years | +95.1% | +534.3% |
VYGR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +391.6% | -3.6% | +534.3% |
| 5 y | 5-year | at high | +391.6% | -3.6% | +534.3% |
| alltime | all time | at high | +6733.1% | -3.6% | +5495.4% |
Voyager Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $329.23 M(-3.6%) |
| Jun 2024 | - | $341.44 M(+1.4%) |
| Mar 2024 | - | $336.58 M(+31.9%) |
| Dec 2023 | $255.18 M(+391.6%) | $255.18 M(+27.4%) |
| Sep 2023 | - | $200.24 M(-15.4%) |
| Jun 2023 | - | $236.78 M(-16.2%) |
| Mar 2023 | - | $282.69 M(+444.6%) |
| Dec 2022 | $51.91 M(-39.4%) | $51.91 M(-29.6%) |
| Sep 2022 | - | $73.70 M(+37.3%) |
| Jun 2022 | - | $53.70 M(-22.2%) |
| Mar 2022 | - | $68.97 M(-19.5%) |
| Dec 2021 | $85.72 M(-49.9%) | $85.72 M(-13.9%) |
| Sep 2021 | - | $99.50 M(-19.7%) |
| Jun 2021 | - | $123.96 M(-18.0%) |
| Mar 2021 | - | $151.09 M(-11.6%) |
| Dec 2020 | $171.00 M(-25.2%) | $171.00 M(-1.9%) |
| Sep 2020 | - | $174.26 M(-2.7%) |
| Jun 2020 | - | $179.13 M(-10.4%) |
| Mar 2020 | - | $199.94 M(-12.6%) |
| Dec 2019 | $228.65 M | $228.65 M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $247.43 M(-8.9%) |
| Jun 2019 | - | $271.63 M(-11.3%) |
| Mar 2019 | - | $306.39 M(+134.2%) |
| Dec 2018 | $130.81 M(-16.1%) | $130.81 M(-14.2%) |
| Sep 2018 | - | $152.44 M(-10.9%) |
| Jun 2018 | - | $171.15 M(-9.8%) |
| Mar 2018 | - | $189.69 M(+21.7%) |
| Dec 2017 | $155.89 M(-5.5%) | $155.89 M(+45.4%) |
| Sep 2017 | - | $107.25 M(-19.3%) |
| Jun 2017 | - | $132.89 M(-11.4%) |
| Mar 2017 | - | $150.02 M(-9.1%) |
| Dec 2016 | $164.98 M(-4.1%) | $164.98 M(-5.0%) |
| Sep 2016 | - | $173.63 M(-6.5%) |
| Jun 2016 | - | $185.72 M(+1.7%) |
| Mar 2016 | - | $182.62 M(+6.2%) |
| Dec 2015 | $171.96 M(+2822.6%) | $171.96 M(+101.7%) |
| Sep 2015 | - | $85.25 M(-1.3%) |
| Jun 2015 | - | $86.40 M(+1368.4%) |
| Dec 2014 | $5.88 M(-253.0%) | $5.88 M |
| Dec 2013 | -$3.85 M | - |
FAQ
- What is Voyager Therapeutics annual working capital?
- What is the all time high annual working capital for Voyager Therapeutics?
- What is Voyager Therapeutics annual working capital year-on-year change?
- What is Voyager Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly working capital year-on-year change?
What is Voyager Therapeutics annual working capital?
The current annual working capital of VYGR is $255.18 M
What is the all time high annual working capital for Voyager Therapeutics?
Voyager Therapeutics all-time high annual working capital is $255.18 M
What is Voyager Therapeutics annual working capital year-on-year change?
Over the past year, VYGR annual working capital has changed by +$203.27 M (+391.59%)
What is Voyager Therapeutics quarterly working capital?
The current quarterly working capital of VYGR is $329.23 M
What is the all time high quarterly working capital for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly working capital is $341.44 M
What is Voyager Therapeutics quarterly working capital year-on-year change?
Over the past year, VYGR quarterly working capital has changed by +$74.06 M (+29.02%)